“PREMIXED INSULIN REGIMEN TO BASAL-BOLUS INSULIN OUTCOMES IN TYPE 2 DIABETES SUBJECTS” (2023) International Research Journal of Pharmacy, 14(2), pp. 40–48. doi:10.56802/enp5vh61.